The Centers for Disease Control and Prevention (CDC) is now monitoring the COVID-19 variant KP.3.1.1 as it edges close to KP.3. "The KP.3.1.1 variant is very similar to other circulating variants in ...

The newest COVID-19 variant isn't as scary as it seemed at first, and fall booster shots should protect against it and other variants circulating now, new data suggests. In a clinical trial, the ...

The center has received 139 submissions for disease modeling, encompassing 191 genetic variants. Half of our submissions are from individuals or programs not affiliated with Baylor College of Medicine ...

The unprecedented infectiousness of XBB.1.5 prompted renewed calls for public caution Friday from New York City health officials, who announced the latest omicron descendant, widely believed to be ...

KP.3.1.1 is still the dominant COVID-19 variant in the United States as it accounts for nearly 60% of positive cases, but the XEC variant is not far behind, recent Centers for Disease Control and ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

• A report from the U.K. Health Security Agency indicates that the Pfizer and AstraZeneca COVID-19 vaccines are each about 90% or more effective at preventing hospitalization and mortality, with ...

Sequencing efforts have improved, but experts say there's a long way to go. This is a MedPage story. The only certain thing about the future of SARS-CoV-2 variants is that nothing is certain -- but ...

Estimates show the variant accounts for over 51% of all new cases nationwide. A highly contagious variant of the novel coronavirus that was initially identified in India is now the dominant strain in ...